Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation

Abstract Faecal calprotectin and faecal occult blood test (FOBT) were widely used in the diagnosis and assessment of intestinal inflammation in inflammatory bowel disease (IBD). Recently we identified an excellent new biomarker B cell-activating factor (BAFF) for IBD. Here in this study we compared...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu Fu, Lingli Wang, Cheng Xie, Kaifang Zou, Lei Tu, Wei Yan, Xiaohua Hou
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/ab8f91a293674f85b359a1e55fa01806
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ab8f91a293674f85b359a1e55fa01806
record_format dspace
spelling oai:doaj.org-article:ab8f91a293674f85b359a1e55fa018062021-12-02T12:32:04ZComparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation10.1038/s41598-017-02835-52045-2322https://doaj.org/article/ab8f91a293674f85b359a1e55fa018062017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02835-5https://doaj.org/toc/2045-2322Abstract Faecal calprotectin and faecal occult blood test (FOBT) were widely used in the diagnosis and assessment of intestinal inflammation in inflammatory bowel disease (IBD). Recently we identified an excellent new biomarker B cell-activating factor (BAFF) for IBD. Here in this study we compared the efficacy of faecal BAFF, calprotectin and FOBT to find the “best non-invasive marker”. Results showed that for discriminating IBD from IBS, BAFF ≥227.3 pg/ml yield 84% sensitivity, 100% specificity, 100% positive predictive value (PPV) and 64% negative predictive value (NPV) while calprotectin ≥50 µg/g yield 76% sensitivity, 93% specificity, 97% PPV and 53% NPV. FOBT yield 65% sensitivity, 93% specificity, 97% PPV and 43% NPV. Combining BAFF with calprotectin tests yield 94% sensitivity, 93% specificity, 98% PPV, 81% NPV. Faecal BAFF level showed the stronger correlation with endoscopic inflammatory score as compared to calprotectin not only in UC (correlation coefficient [r] = 0.69, p < 0.0001 vs. r = 0.58, p < 0.0001), but also in CD (r = 0.58, p < 0.0001 vs. r = 0.52, p = 0.0003). Our results indicating that faecal BAFF is a promising non-invasive biomarker in IBD differential diagnosis and monitoring of intestinal inflammation.Yu FuLingli WangCheng XieKaifang ZouLei TuWei YanXiaohua HouNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yu Fu
Lingli Wang
Cheng Xie
Kaifang Zou
Lei Tu
Wei Yan
Xiaohua Hou
Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
description Abstract Faecal calprotectin and faecal occult blood test (FOBT) were widely used in the diagnosis and assessment of intestinal inflammation in inflammatory bowel disease (IBD). Recently we identified an excellent new biomarker B cell-activating factor (BAFF) for IBD. Here in this study we compared the efficacy of faecal BAFF, calprotectin and FOBT to find the “best non-invasive marker”. Results showed that for discriminating IBD from IBS, BAFF ≥227.3 pg/ml yield 84% sensitivity, 100% specificity, 100% positive predictive value (PPV) and 64% negative predictive value (NPV) while calprotectin ≥50 µg/g yield 76% sensitivity, 93% specificity, 97% PPV and 53% NPV. FOBT yield 65% sensitivity, 93% specificity, 97% PPV and 43% NPV. Combining BAFF with calprotectin tests yield 94% sensitivity, 93% specificity, 98% PPV, 81% NPV. Faecal BAFF level showed the stronger correlation with endoscopic inflammatory score as compared to calprotectin not only in UC (correlation coefficient [r] = 0.69, p < 0.0001 vs. r = 0.58, p < 0.0001), but also in CD (r = 0.58, p < 0.0001 vs. r = 0.52, p = 0.0003). Our results indicating that faecal BAFF is a promising non-invasive biomarker in IBD differential diagnosis and monitoring of intestinal inflammation.
format article
author Yu Fu
Lingli Wang
Cheng Xie
Kaifang Zou
Lei Tu
Wei Yan
Xiaohua Hou
author_facet Yu Fu
Lingli Wang
Cheng Xie
Kaifang Zou
Lei Tu
Wei Yan
Xiaohua Hou
author_sort Yu Fu
title Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
title_short Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
title_full Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
title_fullStr Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
title_full_unstemmed Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation
title_sort comparison of non-invasive biomarkers faecal baff, calprotectin and fobt in discriminating ibs from ibd and evaluation of intestinal inflammation
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/ab8f91a293674f85b359a1e55fa01806
work_keys_str_mv AT yufu comparisonofnoninvasivebiomarkersfaecalbaffcalprotectinandfobtindiscriminatingibsfromibdandevaluationofintestinalinflammation
AT lingliwang comparisonofnoninvasivebiomarkersfaecalbaffcalprotectinandfobtindiscriminatingibsfromibdandevaluationofintestinalinflammation
AT chengxie comparisonofnoninvasivebiomarkersfaecalbaffcalprotectinandfobtindiscriminatingibsfromibdandevaluationofintestinalinflammation
AT kaifangzou comparisonofnoninvasivebiomarkersfaecalbaffcalprotectinandfobtindiscriminatingibsfromibdandevaluationofintestinalinflammation
AT leitu comparisonofnoninvasivebiomarkersfaecalbaffcalprotectinandfobtindiscriminatingibsfromibdandevaluationofintestinalinflammation
AT weiyan comparisonofnoninvasivebiomarkersfaecalbaffcalprotectinandfobtindiscriminatingibsfromibdandevaluationofintestinalinflammation
AT xiaohuahou comparisonofnoninvasivebiomarkersfaecalbaffcalprotectinandfobtindiscriminatingibsfromibdandevaluationofintestinalinflammation
_version_ 1718394177105952768